首页 > 最新文献

Journal of Research in Pharmacy Practice最新文献

英文 中文
Patient Satisfaction with Pharmaceutical Services in Makkah: A Cross-sectional Study. 麦加病人对药品服务的满意度:一项横断面研究。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2022-05-25 eCollection Date: 2021-10-01 DOI: 10.4103/jrpp.jrpp_94_21
Abdulaziz Salamatullah, Majid Ali, Alhanouf Alharbi, Alhanoof Balhmer, Raneem Jalal, Dina Alabdali, Ghufran Alhajjaji

Objective: Patient satisfaction is considered an essential indicator of the treatment outcomes of pharmaceutical services. This study aimed to assess patient satisfaction with the pharmaceutical services at the Ministry of Health (MOH) hospitals in Makkah city in Saudi Arabia.

Methods: A cross-sectional study was conducted via an interview-based questionnaire that involved patients who visited the outpatient pharmacy in five MOH hospitals from August 2018 to September 2018. The data were collected using a previously published, validated, and reliable questionnaire. The questionnaire was translated and piloted for the local context.

Findings: Data of 295 respondents were analyzed. The overall mean score of satisfaction level with the pharmaceutical services was found to be 2.50 out of a maximum score of 3. The item that the patients were most satisfied with was, "The extent of cleanliness in the waiting area for the provision of pharmaceutical services" (mean = 2.80) whereas the item the patients were least satisfied with was, "The information the pharmacist gives you about the proper storage of your medication" (mean = 2.00). "Illiterate" patients and those who visited the pharmacy first time had significantly higher satisfaction levels compared to those with other educational categories and those who had visited the pharmacy before, respectively.

Conclusion: Our study showed that the overall level of satisfaction of patients with pharmaceutical services was high.

目的:患者满意度被认为是衡量药学服务治疗效果的重要指标。本研究旨在评估沙特阿拉伯麦加市卫生部(MOH)医院的患者对药品服务的满意度。方法:采用访谈式问卷,对2018年8月至2018年9月在卫生部5家医院门诊药房就诊的患者进行横断面研究。数据是使用先前发布的、经过验证的、可靠的问卷收集的。根据当地情况对调查表进行了翻译和试用。结果:分析了295名受访者的数据。市民对药剂服务的整体平均满意度为2.50分,满分为3分。患者最满意的项目是“提供药物服务的等候区清洁程度”(平均= 2.80),而患者最不满意的项目是“药剂师告诉你药物的正确存放信息”(平均= 2.00)。“文盲”患者和第一次去药房的患者的满意度分别高于其他教育类别和以前去过药房的患者。结论:我院患者对药学服务的总体满意度较高。
{"title":"Patient Satisfaction with Pharmaceutical Services in Makkah: A Cross-sectional Study.","authors":"Abdulaziz Salamatullah,&nbsp;Majid Ali,&nbsp;Alhanouf Alharbi,&nbsp;Alhanoof Balhmer,&nbsp;Raneem Jalal,&nbsp;Dina Alabdali,&nbsp;Ghufran Alhajjaji","doi":"10.4103/jrpp.jrpp_94_21","DOIUrl":"https://doi.org/10.4103/jrpp.jrpp_94_21","url":null,"abstract":"<p><strong>Objective: </strong>Patient satisfaction is considered an essential indicator of the treatment outcomes of pharmaceutical services. This study aimed to assess patient satisfaction with the pharmaceutical services at the Ministry of Health (MOH) hospitals in Makkah city in Saudi Arabia.</p><p><strong>Methods: </strong>A cross-sectional study was conducted via an interview-based questionnaire that involved patients who visited the outpatient pharmacy in five MOH hospitals from August 2018 to September 2018. The data were collected using a previously published, validated, and reliable questionnaire. The questionnaire was translated and piloted for the local context.</p><p><strong>Findings: </strong>Data of 295 respondents were analyzed. The overall mean score of satisfaction level with the pharmaceutical services was found to be 2.50 out of a maximum score of 3. The item that the patients were most satisfied with was, \"The extent of cleanliness in the waiting area for the provision of pharmaceutical services\" (mean = 2.80) whereas the item the patients were least satisfied with was, \"The information the pharmacist gives you about the proper storage of your medication\" (mean = 2.00). \"Illiterate\" patients and those who visited the pharmacy first time had significantly higher satisfaction levels compared to those with other educational categories and those who had visited the pharmacy before, respectively.</p><p><strong>Conclusion: </strong>Our study showed that the overall level of satisfaction of patients with pharmaceutical services was high.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 4","pages":"174-179"},"PeriodicalIF":1.0,"publicationDate":"2022-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b8/c8/JRPP-10-174.PMC9235369.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40406029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Investigating the Outcomes of Aluminum Phosphide Poisoning in Khorshid Referral Hospital, Isfahan, Iran: A Retrospective Study. 调查伊朗伊斯法罕Khorshid转诊医院磷化铝中毒的结果:一项回顾性研究
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2022-05-25 eCollection Date: 2021-10-01 DOI: 10.4103/jrpp.jrpp_88_21
Gholamali Dorooshi, Meysam Mirzae, Negah Tavakoli Fard, Shafeajafar Zoofaghari, Nastaran Eizadi Mood

Objective: Aluminum phosphide (ALP) (rice-tablet) is a common cause of adult poisoning in Iran, including Isfahan. So far, no effective treatment has been identified for this poisoning. We aimed to investigate the outcome of ALP poisoned patients admitted to the clinical toxicology ward of Khorshid Hospital in Isfahan from 2017 to 2019.

Methods: This chart-review study was performed on the population of ALP poisoned patients admitted to the clinical toxicology ward of Khorshid University Hospital from 2017 to 2019 treated with the hospital's new treatment protocol, using the complete enumeration approach. The outcomes were determined by reviewing and abstracting medical charts of ALP poisoned patients from the hospital archive.

Findings: The most common complaints at admission were depressed consciousness (41.9%) and vomiting (32.2%). There was no significant change in blood sugar, pH, base excess (BE), and venous blood bicarbonate throughout their hospitalization (P > 0.05). Treatment outcomes had a significant relationship with blood pH 2 h and 6 h after admission and the BE 6 h after admission (P < 0.05). There was also a significant relationship between the outcome and the length of stay, initial ejection fraction (EF), and EF in predischarge echocardiography (P < 0.05). Out of 31 patients, 24 (77.4%) died within 72 h, 5 (16.1%) recovered without any complication, and 2 (6.5%) recovered with some complications.

Conclusion: The mortality rate of ALP poisoned patients was reasonably high and can be attributed to the poor efficacy of the new treatment protocol or the long time it takes for patients to reach the hospital and start receiving treatments.

目的:磷化铝(ALP)(米片)是伊朗成人中毒的常见原因,包括伊斯法罕。到目前为止,还没有找到有效的治疗方法。我们的目的是调查2017 - 2019年在伊斯法罕Khorshid医院临床毒理学病房住院的ALP中毒患者的预后。方法:采用完全枚举法,对2017 - 2019年在科尔希德大学医院临床毒理学病房接受该院新治疗方案治疗的ALP中毒患者进行回顾性研究。通过查阅和提取医院档案中ALP中毒患者的病历来确定结果。结果:入院时最常见的主诉为意识低落(41.9%)和呕吐(32.2%)。两组患者住院期间血糖、pH、碱过量(BE)、静脉血碳酸氢盐变化均无统计学意义(P > 0.05)。治疗结果与入院后2 h、6 h血pH及入院后6 h BE有显著相关性(P < 0.05)。出院前超声心动图结果与住院时间、初始射血分数(EF)、EF也有显著相关(P < 0.05)。31例患者中,72 h内死亡24例(77.4%),无并发症痊愈5例(16.1%),有并发症痊愈2例(6.5%)。结论:ALP中毒患者死亡率较高,可能与新治疗方案疗效不佳或患者到达医院开始治疗时间较长有关。
{"title":"Investigating the Outcomes of Aluminum Phosphide Poisoning in Khorshid Referral Hospital, Isfahan, Iran: A Retrospective Study.","authors":"Gholamali Dorooshi,&nbsp;Meysam Mirzae,&nbsp;Negah Tavakoli Fard,&nbsp;Shafeajafar Zoofaghari,&nbsp;Nastaran Eizadi Mood","doi":"10.4103/jrpp.jrpp_88_21","DOIUrl":"https://doi.org/10.4103/jrpp.jrpp_88_21","url":null,"abstract":"<p><strong>Objective: </strong>Aluminum phosphide (ALP) (rice-tablet) is a common cause of adult poisoning in Iran, including Isfahan. So far, no effective treatment has been identified for this poisoning. We aimed to investigate the outcome of ALP poisoned patients admitted to the clinical toxicology ward of Khorshid Hospital in Isfahan from 2017 to 2019.</p><p><strong>Methods: </strong>This chart-review study was performed on the population of ALP poisoned patients admitted to the clinical toxicology ward of Khorshid University Hospital from 2017 to 2019 treated with the hospital's new treatment protocol, using the complete enumeration approach. The outcomes were determined by reviewing and abstracting medical charts of ALP poisoned patients from the hospital archive.</p><p><strong>Findings: </strong>The most common complaints at admission were depressed consciousness (41.9%) and vomiting (32.2%). There was no significant change in blood sugar, pH, base excess (BE), and venous blood bicarbonate throughout their hospitalization (<i>P</i> > 0.05). Treatment outcomes had a significant relationship with blood pH 2 h and 6 h after admission and the BE 6 h after admission (<i>P</i> < 0.05). There was also a significant relationship between the outcome and the length of stay, initial ejection fraction (EF), and EF in predischarge echocardiography (<i>P</i> < 0.05). Out of 31 patients, 24 (77.4%) died within 72 h, 5 (16.1%) recovered without any complication, and 2 (6.5%) recovered with some complications.</p><p><strong>Conclusion: </strong>The mortality rate of ALP poisoned patients was reasonably high and can be attributed to the poor efficacy of the new treatment protocol or the long time it takes for patients to reach the hospital and start receiving treatments.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 4","pages":"166-173"},"PeriodicalIF":1.0,"publicationDate":"2022-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/eb/ef/JRPP-10-166.PMC9235370.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40410000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
High-dose Intravenous Vitamin C in Early Stages of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Double-blind, Randomized, Controlled Clinical Trial. 早期大剂量静脉注射维生素C治疗冠状病毒感染:一项双盲、随机、对照临床试验
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2022-04-01 DOI: 10.4103/jrpp.jrpp_30_22
Zohre Labbani-Motlagh, Shahideh Amini, Rasoul Aliannejad, Anahita Sadeghi, Gita Shafiee, Ramin Heshmat, Mohamadreza Jafary, Mona Talaschian, Maryam Akhtari, Ahmadreza Jamshidi, Mahdi Mahmoudi, Kourosh Sadeghi

Objective: Based on previous studies in the sepsis population, Vitamin C could prevent injuries when administered in high doses and before the damage is established. This study aimed to evaluate the protective potentials of high-dose Vitamin C in the progression of coronavirus disease 2019 (COVID-19).

Methods: A double-blind, placebo-controlled clinical trial was conducted. Patients with moderate-to-severe disease severity based on the World Health Organization definition were enrolled and received 12 g/d Vitamin C (high-dose intravenous Vitamin C [HDIVC]) or placebo for 4 days. Sequential Organ Failure Assessment (SOFA) score as a primary outcome, National Early Warning Score, Ordinal Scale of Clinical Improvement, and cytokine storm biomarkers were recorded on days 0, 3, and 5. Survival was also assessed on day 28 after enrollment.

Findings: Seventy-four patients (37 patients in each group) were enrolled from April 5, 2020, to November 19, 2020, and all patients completed follow-up. A lower increase in SOFA score during the first 3 days of treatment (+0.026 vs. +0.204) and a higher decrease in this parameter in the last 2 days (-0.462 vs. -0.036) were observed in the treatment group. However, these differences did not reach a significance level (P = 0.57 and 0.12, respectively). Other indices of clinical and biological improvement, length of hospitalization, and intensive care unit admission days were the same between the two groups. Treatment did not affect the 28-day mortality.

Conclusion: Among patients with moderate-to-severe disease of COVID-19, the use of HDIVC plus standard care resulted in no significant difference in SOFA score or 28-day mortality compared to the standard care alone.

目的:根据先前对败血症人群的研究,在损伤形成之前,高剂量服用维生素C可以预防损伤。本研究旨在评估高剂量维生素C在2019冠状病毒病(COVID-19)进展中的保护潜力。方法:采用双盲、安慰剂对照临床试验。根据世界卫生组织的定义,纳入疾病严重程度为中重度的患者,接受12 g/d维生素C(高剂量静脉注射维生素C [HDIVC])或安慰剂治疗4天。顺序器官衰竭评估(SOFA)评分作为主要结果,国家早期预警评分,临床改善顺序量表和细胞因子风暴生物标志物在第0,3和5天进行记录。在入组后第28天评估生存。结果:2020年4月5日至2020年11月19日,共入组74例患者(每组37例),所有患者均完成随访。治疗组SOFA评分在治疗前3天的增加较低(+0.026 vs +0.204),在治疗后2天的下降较高(-0.462 vs -0.036)。然而,这些差异没有达到显著水平(P分别= 0.57和0.12)。两组患者的其他临床和生物学改善指标、住院时间、重症监护病房住院天数均相同。治疗对28天死亡率没有影响。结论:在中重度COVID-19患者中,使用HDIVC +标准治疗与单独使用标准治疗相比,SOFA评分和28天死亡率无显著差异。
{"title":"High-dose Intravenous Vitamin C in Early Stages of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Double-blind, Randomized, Controlled Clinical Trial.","authors":"Zohre Labbani-Motlagh,&nbsp;Shahideh Amini,&nbsp;Rasoul Aliannejad,&nbsp;Anahita Sadeghi,&nbsp;Gita Shafiee,&nbsp;Ramin Heshmat,&nbsp;Mohamadreza Jafary,&nbsp;Mona Talaschian,&nbsp;Maryam Akhtari,&nbsp;Ahmadreza Jamshidi,&nbsp;Mahdi Mahmoudi,&nbsp;Kourosh Sadeghi","doi":"10.4103/jrpp.jrpp_30_22","DOIUrl":"https://doi.org/10.4103/jrpp.jrpp_30_22","url":null,"abstract":"<p><strong>Objective: </strong>Based on previous studies in the sepsis population, Vitamin C could prevent injuries when administered in high doses and before the damage is established. This study aimed to evaluate the protective potentials of high-dose Vitamin C in the progression of coronavirus disease 2019 (COVID-19).</p><p><strong>Methods: </strong>A double-blind, placebo-controlled clinical trial was conducted. Patients with moderate-to-severe disease severity based on the World Health Organization definition were enrolled and received 12 g/d Vitamin C (high-dose intravenous Vitamin C [HDIVC]) or placebo for 4 days. Sequential Organ Failure Assessment (SOFA) score as a primary outcome, National Early Warning Score, Ordinal Scale of Clinical Improvement, and cytokine storm biomarkers were recorded on days 0, 3, and 5. Survival was also assessed on day 28 after enrollment.</p><p><strong>Findings: </strong>Seventy-four patients (37 patients in each group) were enrolled from April 5, 2020, to November 19, 2020, and all patients completed follow-up. A lower increase in SOFA score during the first 3 days of treatment (+0.026 vs. +0.204) and a higher decrease in this parameter in the last 2 days (-0.462 vs. -0.036) were observed in the treatment group. However, these differences did not reach a significance level (<i>P</i> = 0.57 and 0.12, respectively). Other indices of clinical and biological improvement, length of hospitalization, and intensive care unit admission days were the same between the two groups. Treatment did not affect the 28-day mortality.</p><p><strong>Conclusion: </strong>Among patients with moderate-to-severe disease of COVID-19, the use of HDIVC plus standard care resulted in no significant difference in SOFA score or 28-day mortality compared to the standard care alone.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"11 2","pages":"64-72"},"PeriodicalIF":1.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9b/33/JRPP-11-64.PMC9926917.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10741987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comparison of Clinical Manifestations of Patients Poisoned with Tricyclic Antidepressants Alone or with Benzodiazepine Intoxication According to the Dose of Benzodiazepines. 单用三环类抗抑郁药与苯二氮卓类药物中毒患者临床表现的比较
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2022-04-01 DOI: 10.4103/jrpp.jrpp_43_21
Gholamali Dorooshi, Rasool Kermani, Ali Mohammad Sabzghabaee, Marjan Mansourian, Nastaran Eizadi-Mood

Objective: Tricyclic antidepressants poisoning (TCA) is associated with cardiovascular complications, electrocardiographic abnormalities, and central nervous system toxicity. This study aimed to compare the clinical manifestations of poisoned patients with tricyclic antidepressants alone or with benzodiazepine (BZD) intoxication according to the dose of BZDs.

Methods: In this case-control study, 120 patients with TCA poisoning were divided into four groups: the first group of TCA poisoning alone, the second group of TCA and BZD poisoning of <7.75 mg, the third group of TCA and B poisoning of 7.75 to 80 mg, and the fourth group of more than 80 mg of TCA and BZD poisoning. Patients' demographic, clinical, and cardiac information was extracted from their records at admission and 6 h after admission.

Findings: Cardiac complications 6 h after referral and total cardiac complications between TCA and TCA low-dose BZD groups were significantly reduced in the low-dose BZD poisoning group. Comparison of TCA and TCA groups with a moderate dose of BZD showed a significant reduction in time six and total cardiac complications. However, due to the significant difference in TCA values between the two groups, the results are not significant. Comparing the two groups of TCA and TCA with a high dose of BZD, both 6-hour cardiac complications and total cardiac complications in the high-dose BZD group, it was significantly reduced. However, the loss of consciousness was also considerably greater in the high-dose BZD group than in the TCA group.

Conclusion: Concomitant BZDs with TCA can reduce cardiovascular complications from TCA poisoning. However, with high doses of BZDs, there is a greater loss of consciousness.

目的:三环类抗抑郁药物中毒(TCA)与心血管并发症、心电图异常和中枢神经系统毒性有关。本研究的目的是比较三环类抗抑郁药单独使用与苯二氮卓类药物(BZD)中毒患者的临床表现。方法:本病例对照研究将120例TCA中毒患者分为四组:第一组单独TCA中毒,第二组TCA联合BZD中毒。结果:转诊后6 h, TCA与TCA低剂量BZD中毒组心脏并发症及总心脏并发症较低剂量BZD组明显减少。TCA组和TCA组与中剂量BZD的比较显示,TCA组的时间6和总心脏并发症显著减少。但由于两组间TCA值差异显著,故结果不显著。TCA组与TCA加BZD高剂量组比较,BZD高剂量组6小时心脏并发症和总心脏并发症均明显减少。然而,高剂量BZD组的意识丧失也明显大于TCA组。结论:BZDs联合TCA可减少TCA中毒后的心血管并发症。然而,服用高剂量的BZDs会导致更严重的意识丧失。
{"title":"Comparison of Clinical Manifestations of Patients Poisoned with Tricyclic Antidepressants Alone or with Benzodiazepine Intoxication According to the Dose of Benzodiazepines.","authors":"Gholamali Dorooshi,&nbsp;Rasool Kermani,&nbsp;Ali Mohammad Sabzghabaee,&nbsp;Marjan Mansourian,&nbsp;Nastaran Eizadi-Mood","doi":"10.4103/jrpp.jrpp_43_21","DOIUrl":"https://doi.org/10.4103/jrpp.jrpp_43_21","url":null,"abstract":"<p><strong>Objective: </strong>Tricyclic antidepressants poisoning (TCA) is associated with cardiovascular complications, electrocardiographic abnormalities, and central nervous system toxicity. This study aimed to compare the clinical manifestations of poisoned patients with tricyclic antidepressants alone or with benzodiazepine (BZD) intoxication according to the dose of BZDs.</p><p><strong>Methods: </strong>In this case-control study, 120 patients with TCA poisoning were divided into four groups: the first group of TCA poisoning alone, the second group of TCA and BZD poisoning of <7.75 mg, the third group of TCA and B poisoning of 7.75 to 80 mg, and the fourth group of more than 80 mg of TCA and BZD poisoning. Patients' demographic, clinical, and cardiac information was extracted from their records at admission and 6 h after admission.</p><p><strong>Findings: </strong>Cardiac complications 6 h after referral and total cardiac complications between TCA and TCA low-dose BZD groups were significantly reduced in the low-dose BZD poisoning group. Comparison of TCA and TCA groups with a moderate dose of BZD showed a significant reduction in time six and total cardiac complications. However, due to the significant difference in TCA values between the two groups, the results are not significant. Comparing the two groups of TCA and TCA with a high dose of BZD, both 6-hour cardiac complications and total cardiac complications in the high-dose BZD group, it was significantly reduced. However, the loss of consciousness was also considerably greater in the high-dose BZD group than in the TCA group.</p><p><strong>Conclusion: </strong>Concomitant BZDs with TCA can reduce cardiovascular complications from TCA poisoning. However, with high doses of BZDs, there is a greater loss of consciousness.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"11 2","pages":"59-63"},"PeriodicalIF":1.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a9/5c/JRPP-11-59.PMC9926914.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10741984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe Ondansetron-associated Hypokalemia in a Patient Diagnosed with Aspiration Pneumonia. 诊断为吸入性肺炎患者的严重昂丹西酮相关低钾血症
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2022-04-01 DOI: 10.4103/jrpp.jrpp_13_22
Atousa Hakamifard, Amir Aria, Mahnaz Momenzadeh

This case report aims to introduce a patient with severe hypokalemia as one of the rare complications of ondansetron injection. The stroke patient was 56 years old and hospitalized in the emergency department with and purulent sputum. The symptoms and lung computed tomography scan confirmed the diagnosis of aspiration pneumonia. A nasogastric tube was inserted, and food gavage was performed for the patient. The treatment was started with meropenem to manage aspiration pneumonia. The patient could not tolerate the gavage. Consequently, ondansetron was prescribed, but severe hypokalemia of 2.5 mEq/l was developed. The causes of hypokalemia were evaluated. The hematological, biochemical, and liver function tests were done, and the potassium level was measured daily. Afterward, causes of hypokalemia was ruled out and with discontinuation of ondansetron the hypokalemia was resolved. Hypokalemia may be caused by ondansetron. It is required that potassium monitoring be always considered during administrating of this medicine.

本病例报告旨在介绍一个严重低钾血症的患者,这是昂丹司琼注射的罕见并发症之一。中风患者56岁,因脓性痰在急诊科住院。症状和肺部计算机断层扫描证实吸入性肺炎的诊断。插入鼻胃管,并对患者进行灌胃。治疗开始时使用美罗培南治疗吸入性肺炎。病人不能忍受灌胃。因此,开了昂丹司琼,但出现了2.5 mEq/l的严重低钾血症。评估低钾血症的原因。完成血液学、生化和肝功能检查,每日测量钾水平。之后,低血钾的原因被排除,停用昂丹司琼后,低血钾得到解决。低钾血症可能由昂丹司琼引起。在给药过程中,需要始终考虑钾监测。
{"title":"Severe Ondansetron-associated Hypokalemia in a Patient Diagnosed with Aspiration Pneumonia.","authors":"Atousa Hakamifard,&nbsp;Amir Aria,&nbsp;Mahnaz Momenzadeh","doi":"10.4103/jrpp.jrpp_13_22","DOIUrl":"https://doi.org/10.4103/jrpp.jrpp_13_22","url":null,"abstract":"<p><p>This case report aims to introduce a patient with severe hypokalemia as one of the rare complications of ondansetron injection. The stroke patient was 56 years old and hospitalized in the emergency department with and purulent sputum. The symptoms and lung computed tomography scan confirmed the diagnosis of aspiration pneumonia. A nasogastric tube was inserted, and food gavage was performed for the patient. The treatment was started with meropenem to manage aspiration pneumonia. The patient could not tolerate the gavage. Consequently, ondansetron was prescribed, but severe hypokalemia of 2.5 mEq/l was developed. The causes of hypokalemia were evaluated. The hematological, biochemical, and liver function tests were done, and the potassium level was measured daily. Afterward, causes of hypokalemia was ruled out and with discontinuation of ondansetron the hypokalemia was resolved. Hypokalemia may be caused by ondansetron. It is required that potassium monitoring be always considered during administrating of this medicine.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"11 2","pages":"87-90"},"PeriodicalIF":1.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5c/7e/JRPP-11-87.PMC9926912.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10741985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effect of Omega-3 Fatty Acids Supplementation on Homocysteine Level in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis. 补充Omega-3脂肪酸对连续腹膜透析患者同型半胱氨酸水平的影响。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2022-04-01 DOI: 10.4103/jrpp.jrpp_67_22
Tahereh Gholipur-Shahraki, Sahar Vahdat, Shiva Seirafian, Morteza Pourfarzam, Shirinsadat Badri

Objective: One of the most common diseases with high morbidity and mortality rates is chronic kidney disease. Cardiovascular disease affects most patients with chronic kidney disorders, particularly patients undergoing dialysis; hence, appropriate prevention and management approaches are essential. This study aimed to evaluate the reduction of inflammatory biomarkers, especially homocysteine, by omega-3 fatty acids in peritoneal dialysis patients.

Methods: This study enrolled 60 peritoneal dialysis patients who met specified inclusion and exclusion criteria and were randomized to intervention or placebo groups. Omega-3 capsules were given at a dose of 3 g/d for 8 weeks. Inflammatory markers, including high-sensitivity C-reactive protein (hs-CRP), homocysteine, albumin, and lipid profile measured before and after the study.

Findings: Results of this trial revealed that the levels of homocysteine, hs-CRP, and albumin did not change significantly during the study. Analysis of lipid profiles before and after intervention showed omega-3 has no significant effect on the level of total cholesterol or low-density lipoprotein cholesterol; However, the level of triglyceride reduced remarkably (P = 0.002). In addition, serum levels of high-density lipoprotein cholesterol increased at the end of the study (P < 0.001).

Conclusion: Omega-3 does not seem to be able to change the inflammatory markers significantly, particularly homocysteine. More extensive trials must be conducted to better understand the impact of omega-3 on inflammatory and nutritional markers, particularly in peritoneal dialysis patients.

目的:慢性肾脏疾病是一种发病率和死亡率都很高的常见疾病。心血管疾病影响大多数慢性肾病患者,特别是接受透析的患者;因此,适当的预防和管理办法是必不可少的。本研究旨在评估omega-3脂肪酸对腹膜透析患者炎症生物标志物,特别是同型半胱氨酸的降低作用。方法:本研究纳入60例符合特定纳入和排除标准的腹膜透析患者,随机分为干预组或安慰剂组。Omega-3胶囊的剂量为3 g/d,持续8周。在研究前后测量炎症标志物,包括高敏c反应蛋白(hs-CRP)、同型半胱氨酸、白蛋白和血脂。结果:本试验结果显示,在研究期间,同型半胱氨酸、hs-CRP和白蛋白的水平没有显著变化。干预前后的脂质谱分析显示,omega-3对总胆固醇或低密度脂蛋白胆固醇水平没有显著影响;然而,甘油三酯水平显著降低(P = 0.002)。此外,在研究结束时,血清高密度脂蛋白胆固醇水平升高(P < 0.001)。结论:Omega-3似乎不能显著改变炎症标志物,特别是同型半胱氨酸。必须进行更广泛的试验,以更好地了解omega-3对炎症和营养指标的影响,特别是对腹膜透析患者的影响。
{"title":"Effect of Omega-3 Fatty Acids Supplementation on Homocysteine Level in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis.","authors":"Tahereh Gholipur-Shahraki,&nbsp;Sahar Vahdat,&nbsp;Shiva Seirafian,&nbsp;Morteza Pourfarzam,&nbsp;Shirinsadat Badri","doi":"10.4103/jrpp.jrpp_67_22","DOIUrl":"https://doi.org/10.4103/jrpp.jrpp_67_22","url":null,"abstract":"<p><strong>Objective: </strong>One of the most common diseases with high morbidity and mortality rates is chronic kidney disease. Cardiovascular disease affects most patients with chronic kidney disorders, particularly patients undergoing dialysis; hence, appropriate prevention and management approaches are essential. This study aimed to evaluate the reduction of inflammatory biomarkers, especially homocysteine, by omega-3 fatty acids in peritoneal dialysis patients.</p><p><strong>Methods: </strong>This study enrolled 60 peritoneal dialysis patients who met specified inclusion and exclusion criteria and were randomized to intervention or placebo groups. Omega-3 capsules were given at a dose of 3 g/d for 8 weeks. Inflammatory markers, including high-sensitivity C-reactive protein (hs-CRP), homocysteine, albumin, and lipid profile measured before and after the study.</p><p><strong>Findings: </strong>Results of this trial revealed that the levels of homocysteine, hs-CRP, and albumin did not change significantly during the study. Analysis of lipid profiles before and after intervention showed omega-3 has no significant effect on the level of total cholesterol or low-density lipoprotein cholesterol; However, the level of triglyceride reduced remarkably (<i>P</i> = 0.002). In addition, serum levels of high-density lipoprotein cholesterol increased at the end of the study (<i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>Omega-3 does not seem to be able to change the inflammatory markers significantly, particularly homocysteine. More extensive trials must be conducted to better understand the impact of omega-3 on inflammatory and nutritional markers, particularly in peritoneal dialysis patients.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"11 2","pages":"80-86"},"PeriodicalIF":1.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/49/4d/JRPP-11-80.PMC9926915.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10741986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Workplace Cyberloafing Behavior among Pharmacists in Pakistan. 巴基斯坦药剂师工作场所网络闲逛行为评估。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2022-04-01 DOI: 10.4103/jrpp.jrpp_29_22
Yun Jin Kim, Muhammad Shahzad Aslam, Ruolan Deng, Qurratul Ain Leghari, Dulmaa Lkhagvasuren, Muhammad Nehal Nadir, Linchao Qian, Saira Shahnaz

Objective: After the commencement of the Internet and the popularity of various electronic devices, cyberloafing has become prevalent in the workplace regardless of professional type, demographic characteristics, and country. Individuals use the Internet for work-irrelevant purposes during work hours, which is believed to have a controversial role in work productivity. However, rare studies have paid attention to the prevalence of cyberloafing behavior among Pakistan pharmacists. Considering pharmacists' essential role in the health sector, this study investigates the prevalence of cyberloafing activities among workplace pharmacists in Pakistan.

Methods: This cross-sectional survey was conducted among 242 registered pharmacists in Pakistan between October 2021 and February 2022 with a structured self-administered online questionnaire. The final sample consisted of 200 valid responses after screening. Data were processed through exploratory factor analysis and confirmatory factor analyses. Pearson Chi-square analysis was also used to test the correlation between factors.

Findings: Descriptive analysis shows that pharmacists spend more time on sharing-related activities and least on gambling/gaming-related activities in the workplace. All the items' Cronbach's alpha values range from 0.923 to 0.927. The analysis indicates that (60%) pharmacists have intermediate Internet skills. The results also suggest that age, Internet usage, and work area have a strong relationship with cyberloafing behaviors which also, in turn, are linked with their perceived Internet skills. This study has important practical implications for pharmacy management in Pakistan.

Conclusion: Cyberloafing behavior is prevalent among Pakistan pharmacists. Our findings could inspire how managers and all other relevant stakeholders could improve the pharmacy system in Pakistan.

目的:在互联网的开始和各种电子设备的普及之后,网络闲逛已经在工作场所变得普遍,无论专业类型,人口特征和国家。个人在工作时间使用互联网做与工作无关的事情,这被认为对工作效率有争议。然而,很少有研究关注巴基斯坦药剂师中网络闲逛行为的流行程度。考虑到药剂师在卫生部门的重要作用,本研究调查了巴基斯坦工作场所药剂师网络闲逛活动的流行程度。方法:本横断面调查于2021年10月至2022年2月期间对巴基斯坦242名注册药剂师进行了结构化的自我管理在线问卷调查。经筛选后的最终样本为200份有效回复。通过探索性因子分析和验证性因子分析对数据进行处理。Pearson卡方分析也用于检验各因素之间的相关性。结果:描述性分析表明,药剂师在工作场所花费更多的时间在与分享相关的活动上,而在与赌博/游戏相关的活动上花费的时间最少。所有条目的Cronbach’s alpha值在0.923 ~ 0.927之间。分析表明(60%)药师具有中等网络技能。研究结果还表明,年龄、网络使用情况和工作区域与网络闲逛行为有很强的关系,而网络闲逛行为又与他们所感知的网络技能有关。本研究对巴基斯坦的药房管理具有重要的实际意义。结论:巴基斯坦药师普遍存在网络闲逛行为。我们的研究结果可以启发管理者和所有其他相关利益相关者如何改善巴基斯坦的药房系统。
{"title":"Assessing the Workplace Cyberloafing Behavior among Pharmacists in Pakistan.","authors":"Yun Jin Kim,&nbsp;Muhammad Shahzad Aslam,&nbsp;Ruolan Deng,&nbsp;Qurratul Ain Leghari,&nbsp;Dulmaa Lkhagvasuren,&nbsp;Muhammad Nehal Nadir,&nbsp;Linchao Qian,&nbsp;Saira Shahnaz","doi":"10.4103/jrpp.jrpp_29_22","DOIUrl":"https://doi.org/10.4103/jrpp.jrpp_29_22","url":null,"abstract":"<p><strong>Objective: </strong>After the commencement of the Internet and the popularity of various electronic devices, cyberloafing has become prevalent in the workplace regardless of professional type, demographic characteristics, and country. Individuals use the Internet for work-irrelevant purposes during work hours, which is believed to have a controversial role in work productivity. However, rare studies have paid attention to the prevalence of cyberloafing behavior among Pakistan pharmacists. Considering pharmacists' essential role in the health sector, this study investigates the prevalence of cyberloafing activities among workplace pharmacists in Pakistan.</p><p><strong>Methods: </strong>This cross-sectional survey was conducted among 242 registered pharmacists in Pakistan between October 2021 and February 2022 with a structured self-administered online questionnaire. The final sample consisted of 200 valid responses after screening. Data were processed through exploratory factor analysis and confirmatory factor analyses. Pearson Chi-square analysis was also used to test the correlation between factors.</p><p><strong>Findings: </strong>Descriptive analysis shows that pharmacists spend more time on sharing-related activities and least on gambling/gaming-related activities in the workplace. All the items' Cronbach's alpha values range from 0.923 to 0.927. The analysis indicates that (60%) pharmacists have intermediate Internet skills. The results also suggest that age, Internet usage, and work area have a strong relationship with cyberloafing behaviors which also, in turn, are linked with their perceived Internet skills. This study has important practical implications for pharmacy management in Pakistan.</p><p><strong>Conclusion: </strong>Cyberloafing behavior is prevalent among Pakistan pharmacists. Our findings could inspire how managers and all other relevant stakeholders could improve the pharmacy system in Pakistan.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"11 2","pages":"73-79"},"PeriodicalIF":1.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/65/0b/JRPP-11-73.PMC9926916.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10741981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community Pharmacists' Knowledge, Attitude, and Nonprescription Dispensing Practices of Antibiotics: An Explorative Study in a Selected City of South India. 社区药剂师对抗生素的知识、态度和非处方配药实践:印度南部某城市的探索性研究。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2022-04-01 DOI: 10.4103/jrpp.jrpp_48_21
K Sarath Kumar, S Saranya, Nagasubramanian Vanitha Rani

Objective: This study aimed to assess the community pharmacists' knowledge of antibiotics, their attitude toward antibiotic usage and antibiotic resistance, and their nonprescription dispensing practices of antibiotics.

Methods: A cross sectional-questionnaire-based study was conducted among 75 community pharmacists practicing in a selected city of South India. Data on their age, years of experience, and educational qualifications were obtained. A modified, 33-items, prevalidated structured questionnaire was used to assess the community pharmacists knowledge, attitude, and nonprescription antibiotic dispensing practices knowledge, attitudes and practices (KAP). The responses obtained were expressed in descriptive statistics. The association between years of experience and their KAP was assessed using Pearson's correlation.

Findings: Most pharmacists (60%) agreed that antibiotics are used for bacterial infections, and 35% believed that antibiotics could be given for pain and inflammation. Fourty-one percentage of pharmacists agreed that dispensing antibiotics without prescription increases the risk of antibiotic resistance. Seventy-two percentage agreed that they are responsible for taking a prominent role in antimicrobial resistance and infection-control programs in healthcare. Only 46% of pharmacists stated that they always dispensed antibiotics only with a prescription, and 56% dispensed antibiotics for longer than the doctor prescribed. Amoxicillin, metronidazole, and cephalexin were the most commonly dispensed antibiotics without a prescription. The most common reason for dispensing antibiotics without a prescription was the fear of losing customers.

Conclusion: The study identified an average KAP interquartile range 1 among community pharmacists, indicating a lack of awareness of antibiotic resistance and dispensing antibiotics without a prescription.

目的:了解社区药师抗菌药物知识、抗菌药物使用态度、抗菌药物耐药性及非处方配药情况。方法:对印度南部某城市的75名社区药剂师进行了横断面问卷调查。获得了他们的年龄、工作年限和教育程度的数据。采用经修改的33项预验证结构化问卷,对社区药师的知识、态度和非处方抗生素调剂实践知识、态度和实践(KAP)进行评估。得到的回答用描述性统计表示。使用Pearson’s correlation来评估经验与KAP之间的关系。结果:大多数药剂师(60%)同意抗生素用于细菌感染,35%的药剂师认为抗生素可用于疼痛和炎症。41%的药剂师同意,在没有处方的情况下分发抗生素会增加抗生素耐药性的风险。72%的人同意,他们有责任在卫生保健领域的抗微生物药物耐药性和感染控制规划中发挥突出作用。只有46%的药剂师表示,他们总是只根据处方配发抗生素,56%的药剂师配发抗生素的时间超过了医生的处方。阿莫西林、甲硝唑和头孢氨苄是最常用的无处方抗生素。在没有处方的情况下分发抗生素最常见的原因是害怕失去客户。结论:该研究发现,社区药师的平均KAP四分位数范围为1,表明缺乏对抗生素耐药性的认识,并且在没有处方的情况下分发抗生素。
{"title":"Community Pharmacists' Knowledge, Attitude, and Nonprescription Dispensing Practices of Antibiotics: An Explorative Study in a Selected City of South India.","authors":"K Sarath Kumar,&nbsp;S Saranya,&nbsp;Nagasubramanian Vanitha Rani","doi":"10.4103/jrpp.jrpp_48_21","DOIUrl":"https://doi.org/10.4103/jrpp.jrpp_48_21","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to assess the community pharmacists' knowledge of antibiotics, their attitude toward antibiotic usage and antibiotic resistance, and their nonprescription dispensing practices of antibiotics.</p><p><strong>Methods: </strong>A cross sectional-questionnaire-based study was conducted among 75 community pharmacists practicing in a selected city of South India. Data on their age, years of experience, and educational qualifications were obtained. A modified, 33-items, prevalidated structured questionnaire was used to assess the community pharmacists knowledge, attitude, and nonprescription antibiotic dispensing practices knowledge, attitudes and practices (KAP). The responses obtained were expressed in descriptive statistics. The association between years of experience and their KAP was assessed using Pearson's correlation.</p><p><strong>Findings: </strong>Most pharmacists (60%) agreed that antibiotics are used for bacterial infections, and 35% believed that antibiotics could be given for pain and inflammation. Fourty-one percentage of pharmacists agreed that dispensing antibiotics without prescription increases the risk of antibiotic resistance. Seventy-two percentage agreed that they are responsible for taking a prominent role in antimicrobial resistance and infection-control programs in healthcare. Only 46% of pharmacists stated that they always dispensed antibiotics only with a prescription, and 56% dispensed antibiotics for longer than the doctor prescribed. Amoxicillin, metronidazole, and cephalexin were the most commonly dispensed antibiotics without a prescription. The most common reason for dispensing antibiotics without a prescription was the fear of losing customers.</p><p><strong>Conclusion: </strong>The study identified an average KAP interquartile range 1 among community pharmacists, indicating a lack of awareness of antibiotic resistance and dispensing antibiotics without a prescription.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"11 2","pages":"51-58"},"PeriodicalIF":1.0,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/53/69/JRPP-11-51.PMC9926913.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10741980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Summary of COVID-19 Vaccine-Related Reports in the Vaccine Adverse Event Reporting System. 疫苗不良事件报告系统中COVID-19疫苗相关报告汇总
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-12-25 eCollection Date: 2021-07-01 DOI: 10.4103/jrpp.jrpp_49_21
Alice C Ceacareanu, Zachary A P Wintrob

Identification of the severe acute respiratory syndrome coronavirus 2 in humans toward the end of 2019 triggered a rapid, intensive effort to develop a vaccine. Among the first three COVID-19 vaccines granted emergency use authorization by the U. S. Food and Drug Administration (FDA) were two mRNA vaccines, never used on a large scale in humans, and one replication-incompetent human adenovirus vector vaccine. Since the beginning of the vaccination efforts in December 2020, almost 220,000 adverse events (AEs) have been reported through the Vaccine Adverse Event Reporting System, a reporting platform administered jointly by the FDA and the Centers for Disease Control to monitor vaccine-related AEs. We queried this database twice (04/23/21 and 05/14/21) and identified the AE reports with valid manufacturer-specific lot numbers (n = 76,336), a subset representing 33.54% of the total reported AEs. Using vaccine and demographic characteristics at the time of each query date, a model was generated to predict significant AEs, such as death. Our regression analysis revealed that the average age (IRR 1.08) and the number of doses administered in an assisted living facility (IRR 1.01) were significantly associated with the number of deaths observed in each lot, whereas the proportion of remaining vaccine shelf-life (IRR 1.30) and the vaccine manufacturer (IRR 1.09) were not. Studies such as this one are vital, as one of the best answers to vaccine hesitancy is reliable data confirming that the available COVID-19 vaccines are safe and not associated with a significantly higher risk of AEs than vaccines for other conditions.

2019年底,在人类中发现了严重急性呼吸综合征冠状病毒2,引发了开发疫苗的快速、密集的努力。在美国食品和药物管理局(FDA)首批批准紧急使用的三种COVID-19疫苗中,有两种mRNA疫苗(从未在人类中大规模使用)和一种复制能力不足的人类腺病毒载体疫苗。自2020年12月疫苗接种工作开始以来,通过疫苗不良事件报告系统(Vaccine adverse Event Reporting System)报告了近22万例不良事件(ae),这是一个由FDA和疾病控制中心联合管理的报告平台,用于监测与疫苗相关的ae。我们查询了该数据库两次(21年4月23日和21年5月14日),并确定了具有有效制造商特定批号的AE报告(n = 76,336),占报告AE总数的33.54%。利用每个查询日期时的疫苗和人口统计学特征,生成一个模型来预测重大ae,如死亡。我们的回归分析显示,平均年龄(IRR 1.08)和在辅助生活设施中给药的剂量(IRR 1.01)与每批观察到的死亡人数显著相关,而剩余疫苗保质期的比例(IRR 1.30)和疫苗制造商(IRR 1.09)则无关。像这样的研究至关重要,因为对疫苗犹豫的最佳答案之一是可靠的数据,证实现有的COVID-19疫苗是安全的,与其他疾病的疫苗相比,不会导致明显更高的不良反应风险。
{"title":"Summary of COVID-19 Vaccine-Related Reports in the Vaccine Adverse Event Reporting System.","authors":"Alice C Ceacareanu,&nbsp;Zachary A P Wintrob","doi":"10.4103/jrpp.jrpp_49_21","DOIUrl":"https://doi.org/10.4103/jrpp.jrpp_49_21","url":null,"abstract":"<p><p>Identification of the severe acute respiratory syndrome coronavirus 2 in humans toward the end of 2019 triggered a rapid, intensive effort to develop a vaccine. Among the first three COVID-19 vaccines granted emergency use authorization by the U. S. Food and Drug Administration (FDA) were two mRNA vaccines, never used on a large scale in humans, and one replication-incompetent human adenovirus vector vaccine. Since the beginning of the vaccination efforts in December 2020, almost 220,000 adverse events (AEs) have been reported through the Vaccine Adverse Event Reporting System, a reporting platform administered jointly by the FDA and the Centers for Disease Control to monitor vaccine-related AEs. We queried this database twice (04/23/21 and 05/14/21) and identified the AE reports with valid manufacturer-specific lot numbers (<i>n</i> = 76,336), a subset representing 33.54% of the total reported AEs. Using vaccine and demographic characteristics at the time of each query date, a model was generated to predict significant AEs, such as death. Our regression analysis revealed that the average age (IRR 1.08) and the number of doses administered in an assisted living facility (IRR 1.01) were significantly associated with the number of deaths observed in each lot, whereas the proportion of remaining vaccine shelf-life (IRR 1.30) and the vaccine manufacturer (IRR 1.09) were not. Studies such as this one are vital, as one of the best answers to vaccine hesitancy is reliable data confirming that the available COVID-19 vaccines are safe and not associated with a significantly higher risk of AEs than vaccines for other conditions.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 3","pages":"107-113"},"PeriodicalIF":1.0,"publicationDate":"2021-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/57/3d/JRPP-10-107.PMC8809454.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39645034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Patients' Satisfaction with the Community Pharmacy Services in Iran. 伊朗社区药房服务患者满意度调查
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2021-12-25 eCollection Date: 2021-07-01 DOI: 10.4103/jrpp.JRPP_21_21
Ali Saffaei, Azadeh Moghaddas, Ali Mohammad Sabzghabaee

Objective: This study aimed to measure patient satisfaction with community pharmacy in Isfahan, Iran, in 2019.

Methods: In this cross-sectional study (2019), we selected 104 pharmacies located in the second largest city of Iran (Isfahan) based on systematic random sampling and at least five clients at different times of a day who finished the process of obtaining medications from the pharmacies were randomly selected for a short and structured interview using the Persian version of the MacKeigan and Larson questionnaire for measuring patients' satisfaction with pharmacy services.

Findings: The reliability of the questionnaire was confirmed after distributing 520 among the patients (r = 0.958). No significant difference was observed between sex, marital status, housing status, and total satisfaction score based on the results. In addition, there was a significant difference between educational levels, location, job status, insurance status, real income, and total score of satisfaction (P < 0.05). Our results revealed acceptable satisfaction in some aspects, such as paying attention to pharmacists, the general condition of the pharmacy, and their technical competence. On the other hand, the patients were not satisfied enough in different aspects, for example, counseling, accessibility to their needed drugs, and expenses.

Conclusion: Patient satisfaction needs to be improved and enhanced in the case of counseling the patients on their medications, and drug accessibility and expenses remain the primary source of dissatisfaction in the studied population, which should be noted by the Iranian Food and Drug Organization and other related authorities.

目的:本研究旨在了解2019年伊朗伊斯法罕社区药房的患者满意度。方法:在这项横断面研究(2019)中,我们基于系统随机抽样的方法,在伊朗第二大城市伊斯法罕(Isfahan)选择了104家药店,并在一天的不同时间随机选择至少5名从药店获得药物的客户,使用波斯语版MacKeigan和Larson问卷进行简短的结构化访谈,以测量患者对药房服务的满意度。结果:在患者中发放520份问卷后,问卷的信度得到证实(r = 0.958)。结果显示,性别、婚姻状况、居住状况及总满意度无显著差异。此外,教育程度、地理位置、工作状况、保险状况、实际收入、满意度总分之间存在显著差异(P < 0.05)。调查结果显示,在对药师的关注、药房的一般情况、药师的技术能力等方面,药师的满意度较高。另一方面,患者在咨询、所需药物可及性、费用等方面的满意度不高。结论:在对患者进行药物咨询方面,患者满意度有待改善和提高,药物可及性和费用仍然是研究人群不满意的主要原因,这应引起伊朗食品和药物组织和其他相关部门的注意。
{"title":"Patients' Satisfaction with the Community Pharmacy Services in Iran.","authors":"Ali Saffaei,&nbsp;Azadeh Moghaddas,&nbsp;Ali Mohammad Sabzghabaee","doi":"10.4103/jrpp.JRPP_21_21","DOIUrl":"https://doi.org/10.4103/jrpp.JRPP_21_21","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to measure patient satisfaction with community pharmacy in Isfahan, Iran, in 2019.</p><p><strong>Methods: </strong>In this cross-sectional study (2019), we selected 104 pharmacies located in the second largest city of Iran (Isfahan) based on systematic random sampling and at least five clients at different times of a day who finished the process of obtaining medications from the pharmacies were randomly selected for a short and structured interview using the Persian version of the MacKeigan and Larson questionnaire for measuring patients' satisfaction with pharmacy services.</p><p><strong>Findings: </strong>The reliability of the questionnaire was confirmed after distributing 520 among the patients (<i>r</i> = 0.958). No significant difference was observed between sex, marital status, housing status, and total satisfaction score based on the results. In addition, there was a significant difference between educational levels, location, job status, insurance status, real income, and total score of satisfaction (<i>P</i> < 0.05). Our results revealed acceptable satisfaction in some aspects, such as paying attention to pharmacists, the general condition of the pharmacy, and their technical competence. On the other hand, the patients were not satisfied enough in different aspects, for example, counseling, accessibility to their needed drugs, and expenses.</p><p><strong>Conclusion: </strong>Patient satisfaction needs to be improved and enhanced in the case of counseling the patients on their medications, and drug accessibility and expenses remain the primary source of dissatisfaction in the studied population, which should be noted by the Iranian Food and Drug Organization and other related authorities.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"10 3","pages":"133-137"},"PeriodicalIF":1.0,"publicationDate":"2021-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f6/3e/JRPP-10-133.PMC8809457.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39947640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Journal of Research in Pharmacy Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1